Episode 06 - Frank Watanabe, CEO & President Arcutis Biotherapeutics

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. This week we welcome Frank Watanabe! CEO and President of Arcutis Therapeutics, where he has been since it's founding in 2016. During that time they have done multiple successful raises, an $160M IPO and have developed more than 2 FDA approved products with a 3rd being reviewed. Before this he was COO and co-founder of Kanan Therapeutics and VP of strategy and corporate development at Kythera. He also held numerous exec roles throughout his time at Amgen and Eli Lilly and was involved in the development and marketing of 3 approved drugs. He was also a commissioned officer in the US Navy reserves for 25 years. Enjoy and stay tuned.